Archive | Life Science ETF’s and Mutual Funds

Immucor(BLUD) Profits Up but Stock Down 8 %

where to purchase Pregabalin Immucor (BLUD) a global leader in providing instrument-reagent systems to the blood transfusion industry ¬†delivered more than expected financial results for the 3rd Quarter of fiscal 2010 ended February 28. Revenue of $80.5M was up 7% from prior year quarter. Gross margin was 69.2% compared to prior year quarter of 71.4%. Diluted earnings per share […]

Continue Reading 0

2009-2010 Life Sciences Portfolio

click The Raygent Model Portfolio was created in February 2009 and will be updated by the end of March 2010.The 14 month YTD performance is up 25%. New buys over past four months were Sequenom (SQNM) and SeraCare (SRLS). Currently under review are Immucor (BLUD) , MicroFluidics (MLFU) , Genomic Health (GHDH) and Genoptix (GXDX). Published […]

Continue Reading 0